Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

Cell Host and Microbe

Volumn 14, Issue 2, 2013, Pages 207-215

  Kostic, Aleksandar D ^a,b,c   Chun, Eunyoung ^d   Robertson, Lauren ^d   Glickman, Jonathan N ^a,e   Gallini, Carey Ann ^d   Michaud, Monia ^d   Clancy, Thomas E ^a,b,f   Chung, Daniel C ^a,g   Lochhead, Paul ^h   Hold, Georgina L ^h   El Omar, Emad M ^h   Brenner, Dean ⁱ   Fuchs, Charles S ^a,b,d   Meyerson, Matthew ^a,b,c   Garrett, Wendy S ^a,b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MIRACA LIFE SCIENCES   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁱ UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER INFILTRATION; CELL INFILTRATION; COLON ADENOMA; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE EXACERBATION; FECES ANALYSIS; FUSOBACTERIUM NUCLEATUM; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

FUSOBACTERIA; FUSOBACTERIUM; FUSOBACTERIUM NUCLEATUM; MUS;

ADENOMA; ANIMALS; CARCINOGENESIS; COLORECTAL NEOPLASMS; CYTOKINES; DISEASE MODELS, ANIMAL; FUSOBACTERIUM NUCLEATUM; HUMANS; LEUKOCYTES; MICE;

EID: 84882354326     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2013.07.007     Document Type: Article

References (42)

1. J.C. Arthur, E. Perez-Chanona, M. Mühlbauer, S. Tomkovich, J.M. Uronis, T.J. Fan, B.J. Campbell, T. Abujamel, B. Dogan, and A.B. Rogers Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
2. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 487 2012 330 337
3. M. Castellarin, R.L. Warren, J.D. Freeman, L. Dreolini, M. Krzywinski, J. Strauss, R. Barnes, P. Watson, E. Allen-Vercoe, R.A. Moore, and R.A. Holt Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma Genome Res. 22 2012 299 306
4. A.T. Chan, N. Arber, J. Burn, W.K. Chia, P. Elwood, M.A. Hull, R.F. Logan, P.M. Rothwell, K. Schrör, and J.A. Baron Aspirin in the chemoprevention of colorectal neoplasia: an overview Cancer Prev. Res. (Phila.) 5 2012 164 178
5. K.R. Cho, and B. Vogelstein Genetic alterations in the adenoma - carcinoma sequence Cancer 70 Suppl 1992 1727 1731
6. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 486 2012 207 214
7. J.L. Coombes, K.R. Siddiqui, C.V. Arancibia-Cárcamo, J. Hall, C.M. Sun, Y. Belkaid, and F. Powrie A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism J. Exp. Med. 204 2007 1757 1764
8. L.M. Coussens, and J.W. Pollard Leukocytes in mammary development and cancer Cold Spring Harb. Perspect. Biol. 3 2011 3
9. P. Dharmani, J. Strauss, C. Ambrose, E. Allen-Vercoe, and K. Chadee Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha Infect. Immun. 79 2011 2597 2607
10. J.A. DiDonato, F. Mercurio, and M. Karin NF-κB and the link between inflammation and cancer Immunol. Rev. 246 2012 379 400
11. D.I. Gabrilovich, and S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat. Rev. Immunol. 9 2009 162 174
12. D.I. Gabrilovich, S. Ostrand-Rosenberg, and V. Bronte Coordinated regulation of myeloid cells by tumours Nat. Rev. Immunol. 12 2012 253 268
13. W.S. Garrett, G.M. Lord, S. Punit, G. Lugo-Villarino, S.K. Mazmanian, S. Ito, J.N. Glickman, and L.H. Glimcher Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system Cell 131 2007 33 45
14. W.S. Garrett, S. Punit, C.A. Gallini, M. Michaud, D. Zhang, K.S. Sigrist, G.M. Lord, J.N. Glickman, and L.H. Glimcher Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells Cancer Cell 16 2009 208 219
15. S.I. Grivennikov, K. Wang, D. Mucida, C.A. Stewart, B. Schnabl, D. Jauch, K. Taniguchi, G.-Y. Yu, C.H. Österreicher, and K.E. Hung Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth Nature 491 2012 254 258
16. U.K. Gursoy, M. Pöllänen, E. Könönen, and V.J. Uitto Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model J. Periodontol. 81 2010 1084 1091
17. Y.W. Han, W. Shi, G.T.J. Huang, S. Kinder Haake, N.-H. Park, H. Kuramitsu, and R.J. Genco Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells Infect. Immun. 68 2000 3140 3146
18. M.S. Hayden, and S. Ghosh NF-κB, the first quarter-century: remarkable progress and outstanding questions Genes Dev. 26 2012 203 234
19. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
20. C. Jobin Colorectal cancer: CRC - all about microbial products and barrier function? Nat Rev Gastroenterol Hepatol 9 2012 694 696
21. S.Z. Josefowicz, L.-F. Lu, and A.Y. Rudensky Regulatory T cells: mechanisms of differentiation and function Annu. Rev. Immunol. 30 2012 531 564
22. V. Kapatral, I. Anderson, N. Ivanova, G. Reznik, T. Los, A. Lykidis, A. Bhattacharyya, A. Bartman, W. Gardner, and G. Grechkin Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586 J. Bacteriol. 184 2002 2005 2018
23. A.D. Kostic, A.I. Ojesina, C.S. Pedamallu, J. Jung, R.G.W. Verhaak, G. Getz, and M. Meyerson PathSeq: software to identify or discover microbes by deep sequencing of human tissue Nat. Biotechnol. 29 2011 393 396
24. A.D. Kostic, D. Gevers, C.S. Pedamallu, M. Michaud, F. Duke, A.M. Earl, A.I. Ojesina, J. Jung, A.J. Bass, and J. Tabernero Genomic analysis identifies association of Fusobacterium with colorectal carcinoma Genome Res. 22 2012 292 298
25. A. Mantovani, and A. Sica Macrophages, innate immunity and cancer: balance, tolerance, and diversity Curr. Opin. Immunol. 22 2010 231 237
26. A. Mantovani, M.A. Cassatella, C. Costantini, and S. Jaillon Neutrophils in the activation and regulation of innate and adaptive immunity Nat. Rev. Immunol. 11 2011 519 531
27. J.R. Marchesi, B.E. Dutilh, N. Hall, W.H.M. Peters, R. Roelofs, A. Boleij, and H. Tjalsma Towards the human colorectal cancer microbiome PLoS ONE 6 2011 e20447
28. A.N. McCoy, F. Araújo-Pérez, A. Azcárate-Peril, J.J. Yeh, R.S. Sandler, and T.O. Keku Fusobacterium is associated with colorectal adenomas PLoS ONE 8 2013 e53653
29. I. Mellman, G. Coukos, and G. Dranoff Cancer immunotherapy comes of age Nature 480 2011 480 489
30. B.-Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
31. M.R. Rubinstein, X. Wang, W. Liu, Y. Hao, G. Cai, and Y.W. Han Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin Cell Host Microbe 14 2013 195 206 this issue
32. B. Ruffell, N.I. Affara, and L.M. Coussens Differential macrophage programming in the tumor microenvironment Trends Immunol. 33 2012 119 126
33. N. Sanapareddy, R.M. Legge, B. Jovov, A. McCoy, L. Burcal, F. Araujo-Perez, T.A. Randall, J. Galanko, A. Benson, and R.S. Sandler Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans ISME J. 6 2012 1858 1868
34. P.D. Scanlan, F. Shanahan, Y. Clune, J.K. Collins, G.C. O'Sullivan, M. O'Riordan, E. Holmes, Y. Wang, and J.R. Marchesi Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis Environ. Microbiol. 10 2008 789 798
35. N. Segata, S.K. Haake, P. Mannon, K.P. Lemon, L. Waldron, D. Gevers, C. Huttenhower, and J. Izard Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples Genome Biol. 13 2012 R42
36. X.J. Shen, J.F. Rawls, T. Randall, L. Burcal, C.N. Mpande, N. Jenkins, B. Jovov, Z. Abdo, R.S. Sandler, and T.O. Keku Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas Gut Microbes 1 2010 138 147
37. J. Strauss, G.G. Kaplan, P.L. Beck, K. Rioux, R. Panaccione, R. Devinney, T. Lynch, and E. Allen-Vercoe Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host Inflamm. Bowel Dis. 17 2011 1971 1978
38. H. Tjalsma, A. Boleij, J.R. Marchesi, and B.E. Dutilh A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects Nat. Rev. Microbiol. 10 2012 575 582
39. G. Trinchieri Cancer and inflammation: an old intuition with rapidly evolving new concepts Annu. Rev. Immunol. 30 2012 677 706
40. J.M. Uronis, M. Mühlbauer, H.H. Herfarth, T.C. Rubinas, G.S. Jones, and C. Jobin Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility PLoS ONE 4 2009 e6026
41. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
42. S. Wu, K.-J. Rhee, E. Albesiano, S. Rabizadeh, X. Wu, H.-R. Yen, D.L. Huso, F.L. Brancati, E. Wick, and F. McAllister A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses Nat. Med. 15 2009 1016 1022